98%
921
2 minutes
20
Background: Cardiac implantable electronic devices (CIED) are a heterogeneous group of medical devices with increasingly sophisticated diagnostic capabilities, which could be exploited in forensic investigations. However, current guidelines are lacking clear recommendations on the topic. The first aim of this systematic review is to provide an updated assessment of the role of postmortem CIED interrogation, and to give practical recommendations, which can be used in daily practice. Secondly, the authors aim to determine the rates of postmortem CIED interrogation and autopsy investigations, the type of final rhythm detected close to death (with a focus on the significance of documented arrhythmias), as well as the role of postmortem CIED interrogation in the determination of final cause/time of death, and any potentially fatal device malfunctions.
Methods: A systematic search in MEDLINE and Scopus aiming to identify reports concerning postmortem human CIED interrogation was performed, including a systematic screening of reference lists. Case reports, letters to the editors, commentaries, review articles or guidelines were excluded, along with studies related to cardiac devices other than CIED. All data were pooled and analyzed using fixed-effects meta-analysis models, and the I statistic was used to assess heterogeneity.
Results: A total of 25 articles were included in the systematic review, enrolling 3194 decedent CIED carriers. Ten studies (40%) had a 100% autopsy rate, whereas in further 6 studies autopsy findings were variably reported; CIED interrogation was available from 22 studies (88%), and it was never performed prior to autopsy. The overall rate of successful postmortem CIED interrogation was 89%, with high heterogeneity among studies, mainly due to device deactivation/battery discharge. Twenty-four percent of CIED carriers experienced sudden cardiac death (SCD), whereas non-sudden cardiac and non-cardiac death (NSCD, NCD) were reported in 37% and 30% of decedents, respectively. Ventricular tachyarrhythmias were recorded in 34% of overall successfully interrogated CIED, and in 62% of decedents who experienced a SCD; of all ventricular tachyarrhythmias recorded, 40% was found in NSCD or NCD. A clear interpretation of the etiological role of recorded arrhythmias in the causation of death required integration with autopsy findings. Overall, potentially fatal device malfunctions were detected in 12% of cases.
Conclusions: Postmortem CIED interrogation is a valuable tool for the determination of the cause of death, and may complement autopsy. Forensic pathologists need to know the potential utility, pitfalls, and limitations of this diagnostic examination to make this tool as much reliable as possible.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.forsciint.2024.112001 | DOI Listing |
JACC Asia
August 2025
Medizinische Klinik und Poliklinik I, Ludwig-Maximilians University Klinikum, Ludwig-Maximilians University München, Munich, Germany; German Center for Cardiovascular Research, Partner Site Munich Heart Alliance, Munich, Germany. Electronic address:
Background: Cardiac implantable electronic device (CIED)-related tricuspid regurgitation (TR) is common. Transcatheter tricuspid valve replacement (TTVR) is feasible with CIEDs in the right ventricle; however, data in this population are limited.
Objectives: This study retrospectively analyzed patients undergoing compassionate-use transjugular TTVR with the LuX-Valve Plus for symptomatic TR with CIEDs from January 2022 to August 2024 at 17 international centers.
Background: Radiation therapy (RT) can cause cardiac implantable electronic device (CIED) malfunction, primarily reset. Given changes in RT and CIED technologies, large observational studies examining malfunction of contemporary CIEDs during modern-day RT are needed to guide clinical practice.
Methods: Electronic medical records of all consecutive patients with CIEDs who underwent RT at a large tertiary cancer center between January 2015 and January 2022 were reviewed.
Europace
August 2025
Department of Cardiology II - Electrophysiology, University Hospital Muenster.
Introduction: CIED patients are routinely advised against physical activity with a risk of collision because of expected damage to the implanted device. However, no data support this practice.
Methods: Sixteen CIED systems (6 pacemakers, 6 ICD, 4 CRT-D) from all manufacturers were implanted subcutaneously in a porcine thorax and increasing weights were dropped on the experimental setting.
Europace
August 2025
Department of Cardiology II-Electrophysiology, University Hospital Muenster, Albert-Schweitzer-Campus 1, 48149 Muenster, Germany.
Aims: Wireless charging capable smartphones may interact with cardiac implantable electronic devices (CIED). We hypothesized that magnetic shielding with a steel plate placed at the back of a smartphone may prevent interaction.
Methods And Results: Sixteen CIED (6 pacemakers and 10 implantable cardioverters/defibrillators) from all manufacturers were consecutively implanted in a subcutaneous and submuscular location in an isolated porcine thorax and connected to an interactive heart simulator.
JACC Cardiovasc Interv
July 2025
Division of Cardiology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois, USA. Electronic address:
Background: In patients with a cardiac implantable electronic device (CIED) using a transvenous right ventricular (RV) lead, transcatheter tricuspid valve replacement (TTVR) results in RV lead entrapment.
Objectives: The authors sought to evaluate outcomes of patients with pre-existing transvenous RV leads undergoing EVOQUE TTVR.
Methods: Patients with a CIED referred for TTVR at 3 centers were evaluated preoperatively by the heart team.